Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Fuel Switching and Insulin Sensitivity: Study Summary

Previous related pageVitamin D, Fuel Switching and Insulin Sensitivity: Full Evidence ReviewNext related pageVitamin D, Fuel Switching and Insulin Sensitivity: Full Evidence Review
Study at a glance

What was studied?

Researchers investigated whether vitamin D changes how the body uses sugar and fat. They studied people, animals and cells. Some studies measured fuel use directly. Others measured insulin responses or activity inside cells.

What did the studies find?

One human trial found an improved laboratory insulin response. Other trials found no clear advantage or had uncertain results. In a small study, the liver responded differently from the overall measurement of glucose removal. Lower vitamin D was not always linked to lower cell activity.

What does this mean?

A better insulin test does not automatically mean better switching between sugar and fat. Body fat can also affect the vitamin D result measured in blood. The direction of that relationship matters when interpreting an association.

What are the limits?

Many studies were small or measured only one part of metabolism. Animal and cell results do not prove a benefit from supplements in people. The evidence does not establish a personal dose, a blood target or a dependable improvement in fuel switching.

Read the full article below ↓

Vitamin D research gives a mixed picture of fuel use and insulin responses. Some experiments find changes, but different studies measure different parts of metabolism. This summary explains why the findings cannot all be called improved fuel switching. For the detailed comparisons and source limitations, read Vitamin D, Fuel Switching and Insulin Sensitivity: Full Evidence Review.

Fuel use is not the same as fuel switching

Metabolic flexibility is the ability to change fuel use when conditions change, such as after a meal. Using sugar or fat at one moment is different from changing between them. The overview Vitamin D and Metabolic Flexibility explains that distinction in a wider physiological setting.

Zhang and colleagues measured energy use in 69 young, healthy adults inside a metabolic chamber. They did not detect clear differences in carbohydrate or fat oxidation between vitamin D status groups. However, participants were not randomly assigned to those groups. The study cannot prove that vitamin D never affects metabolism, and it did not establish a defined fasting-to-feeding switching response.

Petchey and colleagues tested vitamin D3 against placebo for six months in 28 adults with chronic kidney disease; 25 contributed the analysed outcomes. The study combined controlled insulin testing with estimates of fuel oxidation. It found no clear treatment advantage in glucose disposal or fuel handling. Most participants began with relatively sufficient vitamin D status, so the result cannot settle every deficiency setting.

A separate Pathak report described a positive association after a glucose challenge. This is included only as qualitative abstract-level background because its complete material results were unavailable for appraisal. It is not evidence that supplements caused the response.

Insulin findings differ between trials and tissues

Insulin helps regulate glucose handling. A laboratory improvement in insulin response does not necessarily mean better blood glucose control or better fuel switching. These related processes are introduced in Vitamin D and Insulin Signalling and Vitamin D and Glucose Homeostasis.

Lemieux and colleagues randomly assigned 96 adults at high diabetes risk or with newly diagnosed diabetes. After six months, vitamin D3 improved the main clamp-based insulin-sensitivity measure compared with placebo. A clamp tests glucose handling under controlled conditions. Other estimates and glycaemic outcomes did not show clear treatment effects, and recruitment fell short of the intended size. The trial did not demonstrate diabetes prevention or measure fuel switching directly.

Cefalo and colleagues analysed 18 people receiving vitamin D3 or placebo alongside a calorie-restricted diet. The vitamin D group improved from its own starting point, but the comparison of changes between groups was not conclusive. Participant losses and an inconsistency in the allocation counts weaken interpretation. A subgroup defined by the vitamin D level reached after treatment cannot establish an optimal target.

Lontchi-Yimagou and colleagues studied 19 adults and found an improved liver insulin response without a clear overall advantage in glucose disposal. Changes in fat-tissue markers did not establish that reduced inflammation caused the human result. Their separate mouse receptor experiment was a different intervention from giving people vitamin D3.

Cell activity and body fat add important qualifications

Calton and colleagues found higher oxygen use in blood immune cells from adults with lower vitamin D status. That did not mean those cells produced energy more efficiently. Chang and Kim found changes in lipid accumulation and energy-related markers in muscle-cell and rat experiments, but did not directly measure dynamic fuel switching. The physiological context is described in Vitamin D and Mitochondrial Function; the experimental measurements cannot substitute for a demonstrated human benefit.

Mousa and colleagues’ inflammatory trial randomly assigned 65 people, with 54 completing the analysis. Raising vitamin D did not clearly improve the measured inflammatory markers. The same trial’s primary insulin paper reported a null result, used here only as qualitative abstract-level background because its complete material tables were not inspected. The two papers are not independent trials.

Vimaleswaran and colleagues used genetic evidence to investigate direction. Their findings supported higher body mass index contributing to lower vitamin D status more clearly than the reverse direction. Genetic assumptions and population limits remain important. A low vitamin D blood result alongside higher body fat therefore does not by itself show that vitamin D deficiency caused the body fat.

Kang and Wong also reported opposing metabolic contexts involving the vitamin D receptor. They are retained only as qualitative abstract-level background, without numerical or detailed robustness claims. Manipulating a receptor in an experimental model is not the same as taking a supplement.

What can be concluded?

The selected evidence includes a positive insulin-sensitivity trial, null or uncertain clinical comparisons, and biological mechanisms worth distinguishing carefully. It does not establish a reliable supplement-induced improvement in sugar-to-fat switching, universal mitochondrial efficiency or a personal vitamin D target. A change in one laboratory measurement is not proof of an improvement in all aspects of metabolism.

The full review explains the source-specific access limits, participant-flow discrepancies and shared-trial relationships. This summary does not treat unavailable figures or supplements as inspected. Petchey’s author-list erratum adds Emma L. Duncan and does not provide a new efficacy result. The four expressly labelled background reports do not count as additional fully appraised studies.

Sources

Related reading

Original sources

Source

25-Hydroxyvitamin D status does not affect energy metabolism among young, healthy, non-obese adults: a metabolic chamber study

Published in Zhang L, Cai H, Bai X, Xiao W, Cao Z-B, Zhang Y (2024). Frontiers in Endocrinology15:1501818. DOI10.3389/fendo (2024).

Publication details

25-Hydroxyvitamin D status does not affect energy metabolism among young, healthy, non-obese adults: a metabolic chamber study. Zhang L, Cai H, Bai X, Xiao W, Cao Z-B, Zhang Y (2024). Frontiers in Endocrinology15:1501818. DOI10.3389/fendo.2024.1501818; PMID39624819; PMC11608976. DOI: 10.3389/fendo.2024.1501818. PMID: 39624819.

Read more →
Source

Prevailing vitamin D status influences mitochondrial and glycolytic bioenergetics in peripheral blood mononuclear cells obtained from adults

Published in Calton EK, Keane KN, Soares MJ, et al. (2016). Redox Biology10:243 to 250. DOI10.1016/j.redox (2016).

Publication details

Prevailing vitamin D status influences mitochondrial and glycolytic bioenergetics in peripheral blood mononuclear cells obtained from adults. Calton EK, Keane KN, Soares MJ, et al. (2016). Redox Biology10:243 to 250. DOI10.1016/j.redox.2016.10.007; PMID27816874; PMC5097975. DOI: 10.1016/j.redox.2016.10.007. PMID: 27816874.

Read more →
Source

Insulin-sensitizing effects of vitamin D repletion mediated by adipocyte vitamin D receptor: Studies in humans and mice

Published in Lontchi-Yimagou E, Kang S, Goyal A, et al. (2020). Molecular Metabolism42:101095. DOI10.1016/j.molmet (2020).

Publication details

Insulin-sensitizing effects of vitamin D repletion mediated by adipocyte vitamin D receptor: Studies in humans and mice. Lontchi-Yimagou E, Kang S, Goyal A, et al. (2020). Molecular Metabolism42:101095. DOI10.1016/j.molmet.2020.101095; PMID33045433; PMC7585951. DOI: 10.1016/j.molmet.2020.101095. PMID: 33045433.

Read more →
Source

Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial

Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial.

Publication details

Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial. Cefalo CMA, Conte C, Sorice GP, et al. (2018). Obesity26(4):651 to 657. DOI10.1002/oby.22132; PMID29504254; PMC6175391. DOI: 10.1002/oby.22132. PMID: 29504254.

Read more →
Source

Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial

Yet, no trials have examined the effects of vitamin D supplementation on NFκB activity in-vivo in humans.

Publication details

Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial. Mousa A, Naderpoor N, Johnson J, et al. (2017). Scientific Reports7:15154. DOI10.1038/s41598-017-15264-1; PMID29123173; PMC5680306. DOI: 10.1038/s41598-017-15264-1. PMID: 29123173.

Read more →
Source

Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts

Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts.

Publication details

Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. Vimaleswaran KS, Berry DJ, Lu C, et al. (2013). PLoS Medicine10:e1001383. DOI10.1371/journal.pmed.1001383; PMID23393431; PMC3564800. DOI: 10.1371/journal.pmed.1001383. PMID: 23393431.

Read more →
Source

Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status

Published in Pathak K et al.. Nutrition (2017).

Publication details

Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status. Pathak K et al.. Nutrition. 2017;37:37-42. DOI: 10.1016/j.nut.2016.12.007. PMID: 28359360. Qualitative abstract-level background only; not a fully appraised primary unit.

Read more →
Source

Vitamin D supplementation has no effect on insulin sensitivity or secretion in vitamin D-deficient, overweight or obese adults: a randomized placebo-controlled trial

Published in Mousa A et al.. American Journal of Clinical Nutrition (2017).

Publication details

Vitamin D supplementation has no effect on insulin sensitivity or secretion in vitamin D-deficient, overweight or obese adults: a randomized placebo-controlled trial. Mousa A et al.. American Journal of Clinical Nutrition. 2017;105(6):1372-1381. DOI: 10.3945/ajcn.117.152736. PMID: 28490514. Qualitative abstract-level background only; not a fully appraised primary unit.

Read more →
Source

Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis

Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis.

Publication details

Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis. Kang S, Tsai LT, Zhou Y, et al. (2015). Nature Cell Biology17(1):44 to 56. DOI10.1038/ncb3080; PMID25503565; PMC4281178. DOI: 10.1038/ncb3080. PMID: 25503565. Qualitative abstract-level background only; not a fully appraised primary unit.

Read more →
Source

Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice

Published in Wong KE et al.. Journal of Biological Chemistry (2011).

Publication details

Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice. Wong KE et al.. Journal of Biological Chemistry. 2011;286(39):33804-33810. DOI: 10.1074/jbc.M111.257568. PMID: 21840998. Qualitative abstract-level background only; not a fully appraised primary unit.

Read more →